ArticleCureus2026
Single-Stage Laparoscopic-Endoscopic Rendezvous Technique for Choledocholithiasis: Clinical Outcomes From 1008 Consecutive Patients.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTwo-stage management of choledocholithiasis may be associated with procedure-related complications, repeated interventions, and longer hospital stays. While single-stage laparoscopic common bile duct exploration avoids these risks, it requires advanced laparoscopic expertise. We evaluated the outcomes of the single-stage laparoscopic-endoscopic rendezvous (LER) technique in a large, consecutive cohort.
methodsA STROBE-compliant retrospective analysis was conducted on 1,008 consecutive adult patients with symptomatic cholelithiasis and magnetic resonance cholangiopancreatography-confirmed common bile duct stones (≤15 mm) between 2016 and 2024. The primary outcome was procedural success (complete clearance without conversion). Secondary outcomes included 30-day morbidity and post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) incidence.
resultsProcedural success was achieved in 927 patients (92.0%). The mean operative time was 52.4 ± 12.7 minutes. The overall 30-day minor complication rate was 1.9%, with no observed cases of PEP (0%; 95% CI 0-0.4%). Stone number >3 was the sole independent predictor of failure (OR 4.21; p < 0.001). Conclusion: Single-stage LER is a safe, efficient, and reproducible technique that eliminates PEP and provides high ductal clearance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.